Individuals with germline MSH6 mutations are associated with higher risk of developing endometrial carcinomas [23, 24] and generally do not conform to the classic LS presentation with personal and family histories of young-onset colorectal cancer [37]. MSH6 germline mutations are not uncommon in MTS patients [89, 90]. Here, MSH6 is linked to endometrial carcinoma.